A Review of Antibiotic Efficacy in COVID-19 Control

Hamidreza Hekmat1, Aziz Rasooli2, Zeinab Siami3

  • 1Cardiology Department, Ziaeian Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

PubMed

Insights

Antibiotics were frequently used for hospitalized coronavirus disease (COVID-19) patients, often without clear evidence of effectiveness. Further research is crucial to establish appropriate antibiotic use and combat antimicrobial resistance in COVID-19 care.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Critical Care Medicine

Background:

  • Severe acute respiratory disease, including coronavirus disease (COVID-19), is often complicated by secondary infections, increasing mortality.
  • Mitochondria, crucial for cellular processes, are susceptible to various drugs, including antibiotics, which were widely used during the COVID-19 pandemic.
  • The emergence of antimicrobial resistance poses a significant threat, particularly in the context of widespread antibiotic use for viral infections.

Purpose of the Study:

  • To review the literature on the reasons, evidence, and practices surrounding antibiotic use in coronavirus disease 2019 (COVID-19) patients.
  • To assess the empirical use of antibiotics in hospitalized COVID-19 patients and its established effectiveness.
  • To highlight the urgent need for further research into appropriate antibiotic therapy for COVID-19, considering secondary infections and antimicrobial resistance.

Main Methods:

  • A comprehensive literature review was conducted.
  • The review focused on studies examining antibiotic prescription patterns, indications, and outcomes in both inpatient and outpatient COVID-19 settings.
  • Evidence regarding the efficacy of antibiotic treatment in COVID-19 patients was critically evaluated.

Main Results:

  • Antibiotic use was found to be widespread among hospitalized COVID-19 patients, frequently administered empirically.
  • The effectiveness of this empirical antibiotic approach in managing COVID-19 has not been clearly established.
  • Secondary infections contribute significantly to the high mortality rates observed in COVID-19 patients.

Conclusions:

  • The empirical use of antibiotics in COVID-19 patients requires further investigation to determine its true benefit.
  • Developing clear guidelines for antibiotic therapy is essential to address secondary infections and mitigate the growing problem of antimicrobial resistance.
  • Future research should focus on identifying the most appropriate rationale for antibiotic administration in COVID-19 management.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
24
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
17
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.0K
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.5K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
42
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
23